Karyopharm Therapeutics
Utility Patents

Last updated:

List of all Karyopharm Therapeutics patents 12 in total

Status Patent
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Polymorphs of selinexor External link
Filling date: 26 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Hydrazide containing nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Multicyclic compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Hydrazide containing nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Jan 2020
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Polymorphs of Selinexor External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 10 Sep 2019
Grant
Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: (S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-car- bonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer External link
Filling date: 26 Sep 2025 Issue date: 30 Jul 2019

Showing 1 to 12 of 12 patents.